Transce3nd, LLC Royalty Pharma PLC Transaction History
Transce3nd, LLC
- $295 Billion
- Q4 2024
A detailed history of Transce3nd, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Transce3nd, LLC holds 2,407 shares of RPRX stock, worth $77,890. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,407Holding current value
$77,890% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
429Shares Held
291MCall Options Held
557KPut Options Held
80K-
Morgan Stanley New York, NY39.5MShares$1.28 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$745 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$549 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$457 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...